Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding

Vaccine

Volumn 27, Issue 9, 2009, Pages 1433-1439

  Ahmed, Tanvir ^a,b   Svennerholm, Ann Mari ^b   Tarique, Abdullah Al ^a   Sultana, Gazi N N ^c   Qadri, Firdausi ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Chemical   (Bangladesh)

Author keywords

Breast milk; Cholera vaccine; Hypo responsiveness; Infants; Safety; Zinc

Indexed keywords

CHOLERA VACCINE; INACTIVATED VACCINE; ZINC;

ANTIBODY RESPONSE; ARTICLE; BANGLADESH; BREAST FEEDING; CHILD; DIARRHEA; DIET RESTRICTION; DIET SUPPLEMENTATION; DRUG SAFETY; FEMALE; FEVER; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VOMITING; ZINC DEFICIENCY;

ADMINISTRATION, ORAL; ADULT; ANTIBODY FORMATION; BACTERIAL VACCINES; BANGLADESH; BREAST FEEDING; CHOLERA VACCINES; COSTS AND COST ANALYSIS; DEVELOPING COUNTRIES; FEMALE; HUMANS; INFANT; MALE; POVERTY; URBAN POPULATION; VACCINES, INACTIVATED;

EID: 59849112978     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.12.036     Document Type: Article

References (33)

1. Sharma N.C., Mandal P.K., Dhillon R., and Jain M. Changing profile of Vibrio cholerae O1, O139 in Delhi and its periphery (2003-2005). Indian J Med Res 125 May (5) (2007) 633-640
2. Walker R.I. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries. Vaccine 23 May 16 (26) (2005) 3369-3385
3. Clemens J.D., Stanton B.F., Chakraborty J., Sack D.A., Khan M.R., Huda S., et al. B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity. J Infect Dis 155 January (1) (1987) 79-85
4. Qadri F., Chowdhury M.I., Faruque S.M., Salam M.A., Ahmed T., Begum Y.A., et al. Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. Vaccine 25 January 4 (2) (2007) 231-238
5. Richie E.E., Punjabi N.H., Sidharta Y.Y., Peetosutan K.K., Sukandar M.M., Wasserman S.S., et al. Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine 18 May 8 (22) (2000) 2399-2410
6. Jertborn M., Svennerholm A.M., and Holmgren J. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine. Vaccine 14 15 (1996) 1459-1465
7. Domok I., Balayan M.S., Fayinka O.A., Skrtic N., Soneji A.D., and Harland P.S. Factors affecting the efficacy of live poliovirus vaccine in warm climates. Efficacy of type 1 Sabin vaccine administered together with antihuman gamma-globulin horse serum to breast-fed and artificially fed infants in Uganda. Bull World Health Organ 51 4 (1974) 333-347
8. Rennels M.B. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J Infect Dis 174 September (Suppl. 1) (1996) S107-S111
9. Lin F.Y., Ho V.A., Khiem H.B., Trach D.D., Bay P.V., Thanh T.C., et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. New Engl J Med 344 April 26 (17) (2001) 1263-1269
10. Sack D.A., Shimko J., Sack R.B., Gomes J.G., MacLeod K., O'Sullivan D., et al. Comparison of alternative buffers for use with a new live oral cholera vaccine, Peru-15, in outpatient volunteers. Infect Immun 65 June (6) (1997) 2107-2111
11. Albert M.J., Qadri F., Wahed M.A., Ahmed T., Rahman A.S., Ahmed F., et al. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine. J Infect Dis 187 March 15 (6) (2003) 909-913
12. Karlsen T.H., Sommerfelt H., Klomstad S., Andersen P.K., Strand T.A., Ulvik R.J., et al. Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation. Infect Immun 71 July (7) (2003) 3909-3913
13. Osendarp S.J., Prabhakar H., Fuchs G.J., van Raaij J.M., Mahmud H., Tofail F., et al. Immunization with the heptavalent pneumococcal conjugate vaccine in Bangladeshi infants and effects of zinc supplementation. Vaccine 25 April 30 (17) (2007) 3347-3354
14. Qadri F., Ahmed T., Ahmed F., Begum Y.A., Sack D.A., and Svennerholm A.M. Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups. Vaccine 24 March 6 (10) (2006) 1726-1733
15. Jertborn M., Svennerholm A.M., and Holmgren J. Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine 10 2 (1992) 130-132
16. Wenneras C., Qadri F., Bardhan P.K., Sack R.B., and Svennerholm A.M. Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees. Infect Immun 67 December (12) (1999) 6234-6241
17. Qadri F., Ryan E.T., Faruque A.S., Ahmed F., Khan A.I., Islam M.M., et al. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers. Infect Immun 71 August (8) (2003) 4808-4814
18. Qadri F., Mohi G., Hossain J., Azim T., Khan A.M., Salam M.A., et al. Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin Diagn Lab Immunol 2 November (6) (1995) 685-688
19. Tobias J., Lebens M., Bolin I., Wiklund G., and Svennerholm A.M. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae. Vaccine 26 February 6 (6) (2008) 743-752
20. Qadri F., Ahmed T., Wahed M.A., Ahmed F., Bhuiyan N.A., Rahman A.S., et al. Suppressive effect of zinc on antibody response to cholera toxin in children given the killed, B subunit-whole cell, oral cholera vaccine. Vaccine 22 January 2 (3-4) (2004) 416-421
21. Clemens J.D., Jertborn M., Sack D., Stanton B., Holmgren J., Khan M.R., et al. Effect of neutralization of gastric acid on immune responses to an oral B subunit, killed whole-cell cholera vaccine. J Infect Dis 154 July (1) (1986) 175-178
22. Patent US. Buffer composition base and method of formulation for oral vaccine delivery. United States Patent 5741680. http://www.freepatentsonline.com/5741680.html.
23. Clemens J.D., Sack D.A., Chakraborty J., Rao M.R., Ahmed F., Harris J.R., et al. Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines. Vaccine 8 October (5) (1990) 469-472
24. VanDerslice J., Popkin B., and Briscoe J. Drinking-water quality, sanitation, and breast-feeding: their interactive effects on infant health. Bull World Health Organ 72 4 (1994) 589-601
25. Glass R.I., Svennerholm A.M., Stoll B.J., Khan M.R., Hossain K.M., Huq M.I., et al. Protection against cholera in breast-fed children by antibodies in breast milk. New Engl J Med 308 June 9 (23) (1983) 1389-1392
26. Holmgren J., Svennerholm A.M., and Lindblad M. Receptor-like glycocompounds in human milk that inhibit classical and El Tor Vibrio cholerae cell adherence (hemagglutination). Infect Immun 39 January (1) (1983) 147-154
27. Morrow A.L., Ruiz-Palacios G.M., Jiang X., and Newburg D.S. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 135 May (5) (2005) 1304-1307
28. Siegrist C.A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 21 July 28 (24) (2003) 3406-3412
29. Osendarp S.J., Santosham M., Black R.E., Wahed M.A., van Raaij J.M., and Fuchs G.J. Effect of zinc supplementation between 1 and 6 mo of life on growth and morbidity of Bangladeshi infants in urban slums. Am J Clin Nutr 76 December (6) (2002) 1401-1408
30. Sazawal S., Black R.E., Bhan M.K., Jalla S., Sinha A., and Bhandari N. Efficacy of zinc supplementation in reducing the incidence and prevalence of acute diarrhea-a community-based, double-blind, controlled trial. Am J Clin Nutr 66 August (2) (1997) 413-418
31. Jertborn M., Svennerholm A.M., and Holmgren J. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J Clin Microbiol 24 August (2) (1986) 203-209
32. Glass R.I., Svennerholm A.M., Khan M.R., Huda S., Huq M.I., and Holmgren J. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J Infect Dis 151 February (2) (1985) 236-242
33. Svennerholm A.M., Jertborn M., Gothefors L., Karim A.M., Sack D.A., and Holmgren J. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J Infect Dis 149 June (6) (1984) 884-893